Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (7)

« Back to Publications

In vivo validation of novel non-invasive PHP.eB AAVs as a potential therapeutic approach for alpha-synucleinopathies.

Fouka M. et al, (2025), Acta Neuropathol Commun, 13

Decade-Long Prodrome on Neuroimaging: Unique Insight into Probable Corticobasal Degeneration.

Tai XY. et al, (2025), Mov Disord, 40, 1727 - 1729

Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform.

Gonzalez-Robles C. et al, (2025), Mov Disord, 40, 1307 - 1317

Working memory filtering at encoding and maintenance in healthy ageing, Alzheimer's and Parkinson's disease.

Toniolo S. et al, (2025), Sci Rep, 15

Single extracellular vesicle detection assay identifies membrane-associated α-synuclein as an early-stage biomarker in Parkinson's disease.

Yan S. et al, (2025), Cell Rep Med, 6

Serum p-tau217 Is a Prognostic Indicator of Cognitive Impairment in Idiopathic REM Sleep Behavior Disorder

Yan S. et al, (2025), Annals of Neurology

Palindrome-mediated 16p13.3 triplications cause a recognizable neurodegenerative disorder with ataxia

Fasham J. et al, (2025), American Journal of Human Genetics